Associate Professor, Pediatrics, Eastern Virginia Medical School
Pediatric Infectious Disease
Dr. Kenji M. Cunnion, MD
|
|
Give Review
Doctor Kenji M. Cunnion, MD practices Pediatric Infectious Disease. He researched medicine at Duke University School of Medicine. Duke University School of Medicine is a top medical university. Duke University School of Medicine has a rank of 8 in research and a 29 in primary care He received 2 awards: "Regional Top Doctor" and "Fellow (FAAP)". Kenji Cunnion is also published. He has 36 publications published. The lastest publication: "Pneumatosis intestinalis in pediatric acquired immunodeficiency syndrome.'
Publications
- A 1-Year-Old With Mycobacterium tuberculosis Endocarditis With Mass Spectrometry Analysis of Cardiac Vegetation Composition.
- Severe cystic periventricular leukomalacia in a premature infant with capnocytophaga sepsis.
- Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis.
- An 11-year-old male with refractory osteomyelitis.
- Role of molecular diagnostics in the management of infectious disease emergencies.
- A novel peptide inhibitor of classical and lectin complement activation including ABO incompatibility.
- Staphylococcus aureus Surface Protein SdrE Binds Complement Regulator Factor H as an Immune Evasion Tactic.
- Ceftriaxone-Induced Hemolysis in a Child With Lyme Arthritis: A Case for Antimicrobial Stewardship.
- Protease inhibitors decrease IgG shedding from Staphylococcus aureus increasing complement activation and phagocytosis efficiency.
- A comparison of antibacterial activity against Methicillin-Resistant Staphylococcus aureus and gram-negative organisms for antimicrobial compounds in a unique composit...
- Clumping factor A interaction with complement factor I increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phago...
- Sweet syndrome in infancy.
- Hypochlorite killing of community-associated methicillin-resistant Staphylococcus aureus.
- Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b.
- Human astrovirus coat protein: a novel C1 inhibitor.
- Human astrovirus coat protein inhibits serum complement activation via C1, the first component of the classical pathway.
- Serum complement factor I decreases Staphylococcus aureus phagocytosis.
- Role of complement receptors 1 and 2 (CD35 and CD21), C3, C4, and C5 in survival by mice of Staphylococcus aureus bacteremia.
- Peptide inhibitor of complement c1, a novel suppressor of classical pathway activation: mechanistic studies and clinical potential.
- Acute MRSA sinusitis with intracranial extension and marginal vancomycin susceptibility.
- Hyperglycemia inhibits complement-mediated immunological control of S. aureus in a rat model of peritonitis.
- Clinical hypothermia temperatures increase complement activation and cell destruction via the classical pathway.
- Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy.
- Disruption of the alternative pathway convertase occurs at the staphylococcal surface via the acquisition of factor H by Staphylococcus aureus.
- Potent inhibition of the classical pathway of complement by a novel C1q-binding peptide derived from the human astrovirus coat protein.
- Human astrovirus coat protein binds C1q and MBL and inhibits the classical and lectin pathways of complement activation.
- Risk factors for nosocomial pneumonia: comparing adult critical-care populations.
- Case records of the Medical College of Virginia: a 10-year-old girl presenting with an acute onset of abdominal pain.
- Pneumatosis intestinalis in pediatric acquired immunodeficiency syndrome.
- Tumor necrosis factor receptors encoded by poxviruses.
- Capsule production and growth phase influence binding of complement to Staphylococcus aureus.
- Availability of complement bound to Staphylococcus aureus to interact with membrane complement receptors influences efficiency of phagocytosis.
- Complement activation influences Staphylococcus aureus adherence to endothelial cells.
- Cleavage of complement C3b to iC3b on the surface of Staphylococcus aureus is mediated by serum complement factor I.
- Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human eryt...
Schools
Duke University School Of Medicine
Med College Va
Duke University
Doctors Specialties
- Pediatric Infectious Disease Medicine
- Pediatric Infectious Disease
Accepted Insurances
Awards
- Regional Top Doctor
- Fellow (FAAP)
Education
-
Duke University Hospital -
Virginia Commonwealth University Health System -
Duke University School of Medicine
Helpful Reviews
Similar Doctors
|
|
Dr. Edward S. Buescher, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Randall G. Fisher, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David O. Matson, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Laura A. Sass, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Parvathi S. Kumar |